354 related articles for article (PubMed ID: 26459813)
21. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
[TBL] [Abstract][Full Text] [Related]
22. The time trend of breast cancer mortality in Japan.
Kono A; Misumi J; Misumi J
Arch Gynecol Obstet; 2005 Sep; 272(3):187-90. PubMed ID: 15770513
[TBL] [Abstract][Full Text] [Related]
23. Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
Price M; Neff C; Kruchko C; Barnholtz-Sloan JS; Cordeiro BB; Penas-Prado M; Ozer BH; Cimino PJ; Gilbert MR; Armstrong TS; Ostrom QT
J Neurooncol; 2023 Nov; 165(2):279-290. PubMed ID: 37980692
[TBL] [Abstract][Full Text] [Related]
24. Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran.
Khorasani S; Rezaei S; Rashidian H; Daroudi R
Asian Pac J Cancer Prev; 2015; 16(5):1845-50. PubMed ID: 25773835
[TBL] [Abstract][Full Text] [Related]
25. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
26. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
27. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.
Walker EV; Davis FG;
Neuro Oncol; 2019 Feb; 21(3):360-369. PubMed ID: 30649461
[TBL] [Abstract][Full Text] [Related]
28. The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and Other Central Nervous System Categories for Cancer Registry Data.
Ostrom Q; Kruchko C; Neff C; Firth A; Sherman R
J Registry Manag; 2022; 49(4):139-152. PubMed ID: 37260822
[TBL] [Abstract][Full Text] [Related]
29. Years of potential life lost and valued years of potential life lost in assessing premature mortality in Slovenia.
Semerl JS; Sesok J
Croat Med J; 2002 Aug; 43(4):439-45. PubMed ID: 12187522
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic impact of children with brain tumors.
Bleyer WA
Childs Nerv Syst; 1999 Nov; 15(11-12):758-63. PubMed ID: 10603019
[TBL] [Abstract][Full Text] [Related]
31. Avoidable mortality measured by years of potential life lost (YPLL) aged 5 before 65 years in Kyrgyzstan, 1989-2003.
Bozgunchievz M; Ito K
Nagoya J Med Sci; 2007 Jan; 69(1-2):61-70. PubMed ID: 17378182
[TBL] [Abstract][Full Text] [Related]
32. Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
Gittleman H; Cote DJ; Ostrom QT; Kruchko C; Smith TR; Claus EB; Barnholtz-Sloan JS
J Neurooncol; 2017 Sep; 134(2):269-277. PubMed ID: 28667594
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of pediatric primary malignant central nervous system tumors in Iran: a 10 year report of National Cancer Registry.
Beygi S; Saadat S; Jazayeri SB; Rahimi-Movaghar V
Cancer Epidemiol; 2013 Aug; 37(4):396-401. PubMed ID: 23562043
[TBL] [Abstract][Full Text] [Related]
34. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
35. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
Zhang AS; Ostrom QT; Kruchko C; Rogers L; Peereboom DM; Barnholtz-Sloan JS
Neuro Oncol; 2017 May; 19(5):726-735. PubMed ID: 28039365
[TBL] [Abstract][Full Text] [Related]
36. Premature Mortality Due to Malignancies of the Central Nervous System in Canada, 1980-2010.
Pham TM; Sikdar KC; Cheung WY; Roa W; Eckstrand A; Kaposhi B; Shack L
Neuroepidemiology; 2018; 50(3-4):195-200. PubMed ID: 29694962
[TBL] [Abstract][Full Text] [Related]
37. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.
Legler JM; Ries LA; Smith MA; Warren JL; Heineman EF; Kaplan RS; Linet MS
J Natl Cancer Inst; 1999 Aug; 91(16):1382-90. PubMed ID: 10451443
[TBL] [Abstract][Full Text] [Related]
38. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
39. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society.
Albert VA; Koh HK; Geller AC; Miller DR; Prout MN; Lew RA
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):308-10. PubMed ID: 2212128
[TBL] [Abstract][Full Text] [Related]
40. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Ostrom QT; Gittleman H; Fulop J; Liu M; Blanda R; Kromer C; Wolinsky Y; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2015 Oct; 17 Suppl 4(Suppl 4):iv1-iv62. PubMed ID: 26511214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
